[Carbapenem-resistant Acinetobacter baumannii strains]

Tomasz Bogiel1, Joanna Kwiecińska-Piróg, Katarzyna Jachna-Sawicka

  • 1Katedra i Zakład Mikrobiologii Collegium Medicum im. L. Rydygiera w Bydgoszczy Uniwersytet Mikolaja Kopernika w Toruniu.

Medycyna Doswiadczalna I Mikrobiologia
|September 30, 2010
PubMed

Insights

Carbapenem-resistant Acinetobacter baumannii (CRAB) infections are increasing, particularly in hospital settings. Colistin and tobramycin showed the most promise against these resistant strains.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Acinetobacter baumannii is an opportunistic pathogen frequently causing nosocomial infections.
  • Carbapenem resistance in A. baumannii poses a significant threat due to inter-species transmissibility.

Purpose of the Study:

  • To evaluate the isolation frequency and antibiotic susceptibility of imipenem- and/or meropenem-resistant A. baumannii strains.
  • To analyze trends in CRAB infections between 2007 and 2009 at a university hospital.

Main Methods:

  • Retrospective analysis of A. baumannii isolates from 2007-2009.
  • Antimicrobial susceptibility testing using standard microbiological methods.
  • Data collection on patient demographics and sample sources.

Main Results:

  • A significant increase in CRAB isolation frequency was observed, from 4 strains in 2007 to 95 in 2008 and 67 in 2009.
  • Imipenem resistance rose to 27.6% in 2008 and 31.0% in 2009; meropenem resistance reached 31.2% and 34.6% in 2008 and 2009, respectively.
  • Highest in vitro activity against CRAB was demonstrated by colistin (1.5% resistance), tobramycin (8.1% resistance), and ampicillin/sulbactam (24.8% resistance).

Conclusions:

  • CRAB infections show a concerning increasing trend, predominantly in Intensive Care Units and surgical clinics.
  • CRAB strains exhibit high resistance to common antibiotics like fluoroquinolones and chloramphenicol.
  • Colistin and tobramycin remain the most effective therapeutic options against CRAB isolates in this study.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...